To identify regions on the genome linked to plasma leptin levels. DESIGN: Full genome scan with 402 microsatellite markers, spaced B10 cM apart. Data were analyzed using the HasemanElston regression linkage analysis. SUBJECTS: A total of 160 sibling pairs from 59 predominantly African American, obese families recruited to participate in a genetic-epidemiological study of obstructive sleep apnea. MEASUREMENTS: Serum leptin levels adjusted for age, sex, race and body mass index (BMI). RESULTS: Suggestive linkage peaks were observed on chromosomes 2 (P ¼ 0.00170; marker D2S1384), 3 (P ¼ 0.00007; marker D3S3034), 4 (P ¼ 0.00020; marker D4S1652) and 21 (P ¼ 0.00053; marker D21s1411). CONCLUSION: The peak on chromosome 3 is near the gene for glycogensynthase kinase 2 beta, an important factor in glucose homeostasis. Linkage was generally stronger after BMI adjustment, suggesting the potential influence of a number of metabolic pathways on leptin levels other than those that directly determine obesity levels. The evidence of linkage for leptin levels is consistent with prior linkage analyses for cholesterol, hypertension and other metabolic phenotypes.
Introduction
Obstructive sleep apnea (OSA) is a prevalent disorder characterized by repetitive episodes of complete or partial upper airway obstruction during sleep, associated with intermittent hypoxemia and sleep fragmentation. A primary risk factor for OSA is obesity, which is present in 70% of individuals presenting with OSA. OSA occurs commonly in individuals who have one or more components of the metabolic syndrome (syndrome X), 1,2 including obesity, type 2 diabetes and/or insulin resistance, hyperlipidemia and hypertension. As OSA may worsen the cardiovascular consequences of the metabolic syndrome X, the constellation of symptoms that define this syndrome, along with OSA, may be considered part of a new metabolic syndrome, referred to as syndrome Z. 3 Such associations may be explained by causative mechanisms, whereby OSA-related stresses, particularly intermittent hypoxia and sympathetic nervous system activation, stimulate the release of inflammatory cytokines, adhesion factors and hormones, increasing insulin resistance and predisposing to diabetes. 4 Alternatively, common genetic mechanisms may underlie these related traits. 5 Owing to the strong association between obesity and OSA, the hormone leptin may be a relevant intermediate phenotype for OSA. Leptin plays an important role in the regulation of body weight by influencing the areas of the hypothalamus that control satiety and energy metabolism. 6 It also may exert a number of other effects relevant to OSA, such as influencing ventilatory sensitivity to hypercapnia, lung development and sleep architecture. 7 Leptin levels may be regulated through a number of genetic pathways, involving its synthesis, turnover or tissue binding, via proteins such as the hormone precursor proopiomelanocortin (POMC). 8 Previously, suggestive linkage was found in whites for a measure of OSA to chromosomal region 2p23. 3. 9 This region contains the POMC gene, which has also been reported to be linked to leptin. 10 This suggested the potential importance of studying the genetics of leptin in an OSA family cohort. The goal of this analysis was to conduct a linkage analysis for levels of leptin in families assembled for studying the genetics of OSA.
Research design and methods
Data were analyzed from participants in the Cleveland Family Study, an ongoing genetic-epidemiological study of OSA. Subjects were phenotyped for OSA, body mass index (BMI), and other covariates as described previously. 2 Blood was obtained in a sample of subjects during home visits, which were generally conducted in the late afternoon-early evening, and serum was stored frozen at À201. Leptin levels were assayed in batch at the University of Vermont, Laboratory for Clinical Biochemistry Research by ELISA (R&D Systems). Leptin values above the maximum assay level of 120 ng/ml were assigned the maximum value. Genotyping was carried out on a subsample of the total cohort utilizing a B10 cM whole-genome scan with 402 microsatellite markers (Marshfield Medical Research Foundation; Screening Set 10) with an average heterozygosity of 74%. The rate of pedigree inconsistencies averaged less than 1 inconsistency per marker. Individuals were selected for genotyping on the basis of genetic informativity for degree of OSA with oversampling of concordantly affected or extremely discordant sibling pairs, as previously described.
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Both genotyping and leptin data were available on 160 sibling pairs from 181 individuals.
Statistical analysis
The trait analyzed was log-transformed leptin adjusted for age, sex, race, ln(BMI) and ln(BMI) 2 using SAS 8.2. The natural log transform (ln) for leptin was selected because it increased the magnitude of the parent-offspring correlation, and thus heritability, over the untransformed value. The estimated heritability of log-transformed adjusted leptin levels in this sample is 41%. Additional analyses were conducted for leptin residuals without adjusting for BMI, as has been done in other linkage analyses of leptin. [12] [13] [14] [15] Since BMI and age were correlated (r ¼ 0.27, Po0.0001), the latter analyses did not adjust for age, which would have partially adjusted for BMI. After adjusting for BMI, age was not a significant predictor of leptin levels.
Owing to circadian variation in leptin levels, time of day of venipuncture was also explored as a covariate. Secondary analyses excluded subjects with venipuncture performed between 0600 and noon (n ¼ 44). As OSA shows differential patterns of inheritance by race, 16 additional analyses were restricted to African Americans, who represent the majority in this sample. All genetic analyses were conducted using the statistical package S.A.G.E. 17 Race specific marker allele frequencies were estimated by maximum likelihood using the program FREQ and relationships were verified with RELTEST. The proportion of alleles shared identical by descent (IBD) was calculated separately for each race from all available genotyped relatives using the multipoint GENIBD program. IBD sharing was computed at marker locations and 2 cM intervals between markers. As implemented in SIBPAL, linkage was assessed by Haseman-Elston regression (W4 option); that is, a weighted average of the squared siblingpair leptin difference and mean-corrected sum was regressed on the averaged proportion of alleles shared IBD at each marker. The sib-pair trait sum of adjusted leptin levels was included as a covariate in all models, as this effectively estimates the mean correction. Models also considered the sum of pairwise BMI levels and type 2 diabetes (self-reported) status as covariates in the HE linkage regression. Empirical Pvalues were calculated for any nominal value less than 0.001 using 100 000 replicate permutations, the permutations being both within sibships and across sibships of the same size. For comparison purposes, figures include both P-values and LODs, calculated according to the relation: P-value ¼ 0.5 * Pr(x42 * LOD * log e 10), where x is a w 2 random variable with 1 degree of freedom.
Results Table 1 describes the overall sample and the AfricanAmerican subset used in sensitivity analyses. Subjects were an average age of 39.2 years and were predominantly African Americans (69%, representing 61% of the families). The remaining individuals were Caucasian (n ¼ 55) or bi-racial (n ¼ 2). Over 50% of the sample had a BMI that exceeded 30 kg/m 2 . In total, 10% of the sample self-reported physician-diagnosed type 2 diabetes. In all, 18% were probands with laboratory-diagnosed OSA and another 35% had evidence of sleep disordered breathing as defined by an elevated apnea hypopnea index (the index used to quantify OSA). Figure 1 depicts the evidence for linkage from the entire genome scan in models with and without BMI adjustment A genomewide scan for leptin levels EK Larkin et al Figure 1 Linkage to log(leptin) adjusted for age, sex, race and BMI (solid line) and adjusted for sex and race only (dashed line) for all chromosomes. Nominal P-values are presented.
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International Journal of Obesity using all sibling pairs. Nominal P-values are presented for all chromosomes. Loci suggestive of linkage (ie P-value o0.001) were detected on chromosomes 2, 3, 4 and 21. Figure 2 highlights the chromosomes with suggestive evidence for linkage. Empirical P-values are presented whenever the nominal P-value reached the 0.001 level, indicated by the reference line at 3 (Àlog(0.001)). The highest peak was on chromosome 3, (empirical P ¼ 0.00007 after adjusting for BMI) at marker GATA84B12 (D3S3034) located 124 cM from the p terminus. In models that did not adjust for BMI, the highest peak at 218 cM was flanked by markers ATA22E01 and AFM254ve1, with a nominal Pvalue ¼ 0.00173. Peaks were also seen in chromosomes 2, 21 and 4 after adjusting for BMI. Chromosome 2 had a peak at 204 cM, flanked by markers GATA52A04 (D2S1384) and GATA30E06 (D2S2944), empirical P-value ¼ 0.00170. Chromosome 21 had a peak at marker UT1355 (D21s1411, empirical P ¼ 0.00053; 51 cM). Chromosome 4 had a peak at the last marker GATA5B02 (D4S1652, empirical P ¼ 0.00020). Figure 3 summarizes variation of the linkage peaks with different sampling schemes. Results were stronger for chromosome 3, when analysis was restricted to African Americans. After further adjusting the African-American data for diabetes status, P-values became more significant, except for chromosome 21. Linkage results were slightly stronger for chromosome 2 when sibling pairs with blood draws before noon were excluded, and slightly weaker for chromosomes 3, 4 and 21, compared to results without restricting the sample to those with blood draws after noon. Results were also similar when time of day was considered as a covariate (data not shown).
Secondary analyses were performed exploring how BMIadjusted leptin levels varied with fasting insulin level, a marker of the metabolic syndrome, in a sample of the parent cohort (the Cleveland Family Study) of this study. Among 343 current study participants from the parent cohort in whom fasting blood was available, fasting insulin levels and leptin levels were significantly correlated, after adjusting for BMI, age, sex and race (r ¼ 0.26; Po0.001).
Discussion
In this family sample designed to examine the genetics of OSA, a condition highly related to diabetes and obesity, evidence for linkage to leptin levels was observed on chromosomes 2, 3, 4 and 21. Evidence for linkage increased when considering the smaller sample of African Americans only, and did not change substantially in the subsample that included only individuals with leptin levels drawn after the normal early morning peak in leptin secretion. 18 The peak on chromosome 4 can be viewed as a potential new peak, while the others are near candidate genes for various components of the metabolic syndrome. We analyzed leptin values that were both unadjusted and adjusted for BMI. Although BMI and leptin levels are highly correlated (r ¼ 0.67, Po0.0001), with adipocytes serving as the major source for leptin production, leptin levels may also be influenced by secretion from sources in the brain, and are influenced by a variety of circulating hormones and the sympathetic nervous system. 19, 20 BMIadjusted levels may provide information on leptin's effects on energy balance, independent of effects directly related to BMI, and possibly more directly attributable to other hormonal influences, such as insulin and glucocorticoidsteroids. 21 We found that BMI-adjusted leptin levels provided more evidence for linkage than the unadjusted values. BMI, sex and age adjusted leptin levels have also been utilized as the outcome in a genome scan performed on Pima Indians, with BMI-adjusted levels interpreted as 'relative plasma leptin,' or 'a measure of leptin action.' 22 In contrast to our findings, this latter analysis did not identify any significant linkage peaks in models that adjusted for BMI. Previous research suggests that leptin levels, even after adjusting for BMI, are associated with multiple features of the metabolic syndrome. 23 In exploratory analyses of subjects participating in a current protocol requiring fasting venipuncture, leptin levels adjusted for BMI, age and sex were significantly correlated with insulin, suggesting the potential relevance of this trait in insulin signaling pathways. The peaks observed in this analysis were near genes encoding for several metabolic pathways. We did not, however, observe linkage of leptin levels to chromosome 7, where the leptin gene is, to chromosome 1, where the leptin receptor is, 24 or to the region on chromosome 2p of the gene for POMC. 25 Failure to demonstrate evidence for linkage of leptin to chromosome 7 has been observed in other linkage analyses, 26, 27 and a recent meta-analysis showed no association between the common leptin receptor and measures of body weight. 28 In our cohort of predominantly obese individuals, leptin levels may be more strongly determined by genes that code for related metabolic pathways that modulate leptin levels (eg circulating neurotransmitters, inflammatory cytokines, corticosteroids, insulin, etc), or those that influence tissue sensitivity to leptin, than by the leptin gene or receptor itself. Recent animal work, showing complex interactions between leptin and insulin signaling pathways, and their modification by obesity, underscores the complexity of this phenotype, and the close relationship between insulin and leptin resistances. 29 The peak on chromosome 3 is near the gene coding for glycogen synthase kinase 3 beta (GSK3B), a protein kinase that regulates numerous intracellular signaling pathways and is abundantly expressed in the brain where it may be involved in signal transduction. If replicated, this finding would suggest that leptin levels may be partly determined by genes involved in insulin signaling and nutrient regulation. This would be consistent with animal data demonstrating leptinmediated effects on gluconeogenesis and glycogenolysis. 30 Leptin antagonizes the action of insulin on expression of the A genomewide scan for leptin levels EK Larkin et al Figure 2 Linkage to log(leptin) adjusted for age, sex, race and BMI (solid line) and adjusted for sex and race only (dashed line). Only chromosomes with nominal P-values o0.001 are displayed. Empirical P-values are presented whenever the nominal P-values exceeded the reference line. For chromosome 2, empirical P-values fell below the reference line. Some marker labels were removed for legibility.
glucokinase and phosphoenolpyruvate genes, and inhibits the phosphorylation of glycogen synthase.
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A genome scan for resting heart rate in 513 African Americans from the Hypergen study found a peak at this same location on chromosome 3 (124 cM) for resting heart rate, after adjusting for a series of covariates including BMI (LOD 1.35) . 32 Evidence suggests that increased sympathetic nervous system activity, measured by a resting heart rate, is related to aspects of insulin resistance syndrome. 33, 34 A linkage analysis for adiponectin in Pima Indians, not treated pharmacologically for diabetes, demonstrated a peak (LOD ¼ 1.8-1.9) at the same location (124 cM) with and without adjusting for BMI. 35 Adiponectin, similar to leptin, is a hormone secreted by adipocytes and believed to be an important regulator of insulin sensitivity. The peak on chromosome 2 at 2q34 (204 cM) is approximately 20 cM away from the gene for insulin receptor substrate-1 (IRS1), a diabetes candidate gene at 2q36. This protein plays a key role in insulin signaling and insulin resistance. Recent literature has shown that a high-fat diet and leptin administration alter IRS1-associated phosphatidylinositol 3-kinase activity and glucose transport. 36 Regions of mouse chromosomes orthologous to the human chromosome 2q reveal several interesting obesity related genes including ob7q (gonadal/mesenteric fat), bw5 (body weight) and q1w1/skl1 (late weight gain).
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The peak on chromosome 2, observed in our predominantly African American cohort, is also similar to peaks found for metabolic syndrome and other cardiovascular phenotypes in African American and other samples. For example, in a study of African-American hypertensive sibships that excluded diabetics, researchers found peaks at 181 and 230 cM. 38 The fact that our signals are stronger (P ¼ 0.00031 at 204 cM) in African Americans after adjusting for diabetes, supports the similarity of the peaks. In a sample of old order Amish, linkage to chromosome 2 at 220 cM was found for systolic and diastolic blood pressures. 39 Tang et al 40 found a peak at 240 cM for a multiple metabolic syndrome phenotype; however, a key difference is that our analysis reveals a peak after adjusting leptin for BMI. The stronger linkage observed after adjusting for diabetes suggests that either the leptin pathway is independent of type 2 diabetes or that insulin/hypoglycemic therapy might affect leptin levels.
The peak on chromosome 4 near the last marker (208 cM) may be an artifact in this analysis, because IBD sharing is calculated with less information at the extremes of a chromosome. It is worth noting, however, that the main finding of the 41 genome scan for resting heart rate is a linkage peak in both Caucasians and African Americans at 195 cM located on chromosome 4. Chromosome 21 (UT1355, empirical P ¼ 0.00053, 51 cM) represents a potential new peak for leptin, but has been observed in other metabolic phenotypes. A peak on chromosome 21 lies near sites seen for LDL (LOD ¼ 1.75), total cholesterol (LOD ¼ 2.25) and triglycerides (LOD ¼ 2.9) in African-American hypertensive sibling pairs. 42, 43 This suggests the location of a gene with pleiotropic effects on cardiovascular and metabolic risk factors. When leptin is unadjusted for BMI, a peak is located near the end of chromosome 3 (closest marker: ATA22E01, D3S2418; 216cM, P ¼ 0.00173). This is proximal to a secondary small peak (LOD ¼ 1.5) found in African Americans, 44 and also to a cluster of peaks for metabolic phenotypes on 3q27, including BMI, waist circumference, hip circumference, weight, insulin and insulin/glucose. 45 Several other linkage studies have also confirmed linkage peaks to this region for BMI and a variety of metabolic traits. [46] [47] [48] Relevant candidate genes on 3q27 include adiponectin (APM1), glucose transporters (GLUT2) and apoliprotein D. This report is based on a cohort originally assembled to study OSA. Many subjects had recurrent nocturnal hypoxia, and this may influence insulin resistance directly. 49 OSA is also associated with increased sympathetic drive, 50 which plays a key role in leptin's metabolic effects. 20 The linkages observed may reflect genetic associations that are most operative in settings of elevated insulin levels and sympathetic system activationFtwo factors that may modify leptin levels, or possibly reflect effects of hypoxia-sensitive genes. Thus, the strength of these findings, despite the relatively small sample size, may reflect the particularly strong expression of genetic determinants on a background environment of intermittent hypoxia and sympathoexcitation. Alternatively, the findings may reflect selection processes that enhanced the representation of mostly obese individuals with high genetic risk factors for a complex metabolic-sleep apnea syndrome. It is always possible, as with any genome scan study, that our results are the spurious result of type I error. Future replication of results will be necessary. A genomewide scan for leptin levels EK Larkin et al A limitation of the study is that leptin levels were derived from serum obtained by venipuncture made during a home research visit, which may have varied somewhat in time across the day. As venipuncture times were not strictly standardized, it would be expected that this would introduce random error and mask linkage peaks. However, an extensive series of sensitivity analyses indicated that any random error so introduced did not substantially alter the findings. Adjusting for time of day as a covariate prior to linkage did not alter the results, nor did excluding data from morning blood draws.
In summary, linkage peaks were observed on chromosomes 2, 3, 4 and 21 after adjusting for age, sex, race and BMI. Linkage was generally stronger after BMI adjustment, suggesting the potential influence of a number of metabolic pathways on leptin levels other than those that directly relate to obesity. Associations with BMI-adjusted leptin levels may identify variations in leptin homeostasis that reflect other metabolic and nervous system factors and not simply increased fat mass. Evidence for linkage is consistent with other linkage analyses for metabolic phenotypes. The results are largely driven by the African Americans, who comprise the largest percentage of this sample. Further work will need to assess potential ethnic differences in leptin and other metabolic pathways, and the extent to which such variation influences ethnic susceptibility to cardiovascular diseases and diabetes.
